1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
SEERS Co. Ltd.

SEERS Co. Ltd.

KKRX:458870
23,700.00
KRW
+700.00
(+3.04%)
1,091.88EPS
35.61P/E
1.49TMarket Cap
Nov 13Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2,818.11
1,056.4
198.45
35.65
57.34
229
1,277.09
2,554.22
Basic EPS, GAAP
-3,894
-5,544.33
-634.33
-247
-301.67
-250.81
426.55
1,102.17
Free Cash Flow per Basic Share
-4,504.49
-4,331.04
-678.97
-537.17
-261.1
-325.32
12.05
410.26
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-108.26
129.41
510.38
488.27
219.85
568.29
1,041.23
1,795.47
Tangible Book Value per Share
-108.81
127.65
509.08
486.77
218.86
567.57
1,037.25
1,791.47
Basic Weighted Avg Shares
- -
1
7
32
33
35
38
38
Sales/Revenue/Turnover
1,397
639
1,386
1,153
1,885
8,100
48,171
97,050
Operating Margin (%)
-115.63
-487.32
-316.63
-693.03
-519.48
-107.18
33.89
43.52
Depreciation Expense
164
157
328
511
989
1,124
1,309
1,561
Net Income, GAAP
-1,931
-3,355
-4,431
-7,988
-9,917
-8,871
16,089
41,878
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
0.36
- -
Profit Margin (%)
-138.18
-524.83
-319.64
-692.86
-526.1
-109.53
33.4
43.15
Working Capital
-2,448
6,183
19,113
9,145
-858
12,562
29,640
57,192
LT Debt
1,294
1,068
118
24
1,409
1,103
1,524
1,333
Total Equity
-3,993
4,773
18,824
18,008
8,108
21,399
39,621
68,357
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
47.95
85.13
Return on Capital (%)
- -
- -
- -
- -
- -
- -
48.23
85.09
Return on Common Equity (%)
- -
- -
-37.55
-43.38
-75.94
-60.13
52.78
92.04

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,290
2,336
3,874
LT Borrowings
- -
- -
- -
LT Finance Leases
1,524
1,440
1,333
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
38
38
38
Market Capitalization
1,647,831
1,891,569
1,493,845

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
40,444
59,227
70,744
Cash, Cash Equivalents & STI
11,096
14,335
25,920
Accounts Receivable, Net
22,015
38,535
32,017
Inventories
4,007
4,144
6,924
Total Current Liabilities
10,805
15,609
13,552
Payables & Accruals
- -
- -
- -
ST Debt
2,290
2,336
3,874
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
96.83%
85.15%
Free Cash Flow
- -
45.36%
-103.95%
Net Income, GAAP
- -
-31.08%
-281.36%
Sales/Revenue/Turnover
- -
197.58%
494.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
746
884
984
5,485
8,100
2025
4,068
7,954
15,737
20,412
48,171
2026
32,526
28,376
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-81.67
-89.67
-92.67
7.46
-250.81
2025
-5.33
13.33
177.75
222.21
426.55
2026
361.36
340.4
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Young-Shin Lee
Full Time Employees
130
Sector
Health technology
Industry
Medical specialties
Address
291-13, Dongbu-daero Pyeongtaek-si GY South Korea 17707
IPO Date
Jun 19, 2024
Website
seerstech.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Seers Technology Co., Ltd. (KOSDAQ: 458870.KQ) develops and provides telemedicine solutions focused on remote patient monitoring and medical AI technologies in South Korea. The company offers core products including wearable biosensors such as ECG patches, temperature patches, and pulse oximeters; mobiCARE +Cardio, a cardiac monitoring solution comprising bio patches, patient mobile apps, and cloud-based analysis software; mobiCARE +Home, an integrated telemedicine platform with medical gateways, data processing software, and applications for medical staff; central patient monitoring systems for real-time inpatient oversight; AI-based diagnostic support software for arrhythmia detection and ECG analysis; medical adhesive materials; and customized solutions for outpatient ECG monitoring, in-hospital bedside monitoring, and cardiac rehabilitation. Seers Technology operates primarily in the digital healthcare sector, targeting hospitals, clinics, and telemedicine providers with adoption by over 400 hospitals nationwide; it maintains headquarters in Pyeongtaek-si, Gyeonggi-do, South Korea, along with an R&D center in Seongnam-si and a Jeju branch, and was founded in 2009. Recent developments include the launch of Korea's first subscription-based ECG analysis service, commercialization contracts for inpatient monitoring systems to support smart hospital infrastructure, and expansion into global markets through exports of remote patient monitoring systems.